Nuveen »

Acrivon Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2025-03-31 $27k 13k 2.03

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Nuveen

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Citadel Advisors
Wellington Management Company
UBS Group
Vanguard Group
Renaissance Technologies
Acorn Capital Advisors
BlackRock
Two Sigma Investments
Jane Street
Geode Capital Management
Millennium Management
Marshall Wace
Two Sigma Advisers

View all funds holding Acrivon Therapeutics